Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: Bob B. who wrote (106717)	1/29/2004 3:22:16 PM
From: Fiscally Conservative	Respond to of 208838

Bob Momemtum is all I need to see and the rest usually follows. I could be wrong here,but my gut is telling me this baby wants to blast off.

To: Bob B. who wrote (106717)	1/29/2004 3:38:45 PM
From: Findit	Read Replies (1) \| Respond to of 208838

Bob I have traded RCO several times this year and done pretty well. My current position is mostly from .60 and I have held it longer than I planned. It had a nice attack toward a buck a couple of months ago and backed off. Its fundies are not very good, but its product looks like it has a lot of potential in the healthcare area. Fits right in with the administration's goal of increasing efficiency. A takeover is not out of the question which could lead to a big payday. I'm holding mostly for momentum but also like the stock a lot and may hold some shares for the long run. MHO. Jim From their profile - The Company has focused on electronic prescribing of drugs, laboratory orders and results because these represent the majority of the transactions performed at the point-of-care, and remain largely a paper-based starting point for transferring information in the healthcare system. Its goal is to close the gap in electronic or automated processing by providing technologies and workflow processes at the point of care. The Company's technologies would enable point-of-care providers to connect with other participants in the healthcare system. The Company is focused primarily on healthcare value chain intermediaries.